PRODUCTS
SERVICES
The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
2.38
2 yrs 0 m
1%
491.85 Crs
1% on or before 1M, Nil after 1M
Mid Growth
8
SIP 100 & Lumpsum 500
NA
Ramesh Mantri,Dheeresh Pathak,Piyush Baranwal
Investors understand that their principal will be at very high risk